(Q33732740)
Statements
1 reference
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study (English)
1 reference
Margaret A Phillips
Julie Lotharius
Thomas Rückle
Stephan Chalon
Suzanne Elliott
Silvana Sekuloski
Caroline L Ng
Louise Marquart
Noelle S Williams
Nathalie Gobeau
Lidiya Bebrevska
Maria Rosario
Kennan Marsh
28 March 2017
1 reference
1 reference